Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
Oncology Letters|October 19, 2013
Transformed lymphoplasmacytic lymphoma involving the main carina: A case reportMakoto Nakao, Tetsuya Oguri, Mikinori Miyazaki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 20, 2022
Tolerability, adverse events, and efficacy of treatment for Mycobacterium avium complex pulmonary disease in elderly patientsYuta Mori, Yutaka Ito, Norihisa Takeda, et al.Arerugi = [Allergy]|December 5, 2008
[Management of difficult-to-treat asthma using a flow sheet for systematic evaluation and therapeutic intervention]Hisashi Wakayama, Tomohiko Ogasawara, Ai Sato, et al.Biomedical Reports|November 25, 2016
Organic cation transporter 6 directly confers resistance to anticancer platinum drugsTetsuya Oguri, Eiji Kunii, Satoshi Fukuda, et al.Anticancer Research|September 9, 2018
Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the <i>EGFR</i> T790M Mutation After Failure of Initial EGFR-TKI TreatmentHiromi Furuta, Takehiro Uemura, Tatsuya Yoshida, et al.Internal Medicine (Tokyo, Japan)|August 13, 2025
Clinical and Pathophysiological Characteristics of Patients in Whom Asthma Developed During Treatment with Immune Checkpoint Inhibitors: A Retrospective Single-center StudyKen Maeno, Tomoko Tajiri, Satoshi Fukuda, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
A folylpoly-γ-glutamate synthase single nucleotide polymorphism associated with response to pemetrexed treatment combined with platinum for non-small cell lung cancerSatoshi Fukuda, Tetsuya Oguri, Eiji Kunii, et al.Molecular and Clinical Oncology|August 16, 2017
Osimertinib-induced interstitial lung disease in a patient with non-small cell lung cancer pretreated with nivolumab: A case reportOsamu Takakuwa, Tetsuya Oguri, Takehiro Uemura, et al.Cancer Science|August 10, 2020
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancerYusuke Kagawa, Hiromi Furuta, Takehiro Uemura, et al.Cancer Chemotherapy and Pharmacology|September 19, 2019
ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancerTakehiro Uemura, Tetsuya Oguri, Ken Maeno, et al.Pageof 11